These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8551408)

  • 41. Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.
    Shergy WJ; Polisson RP; Caldwell DS; Rice JR; Pisetsky DS; Allen NB
    Am J Med; 1988 Dec; 85(6):771-4. PubMed ID: 3195601
    [TBL] [Abstract][Full Text] [Related]  

  • 42. British isles survey of methotrexate monitoring practice during treatment of juvenile idiopathic arthritis.
    Hawley DP; Camina N; Rangaraj S
    Semin Arthritis Rheum; 2011 Feb; 40(4):358-64.e1-2. PubMed ID: 20822799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: an observational study with patients from the German Methotrexate Registry.
    Klein A; Kaul I; Foeldvari I; Ganser G; Urban A; Horneff G
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1349-56. PubMed ID: 22649024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral low-dose methotrexate (MTX) to be efficient in refractory rheumatoid arthritis and adult-onset Still's disease.
    Kenouch S; Fessi H; Méry JP; Belmatoug N; Kahn MF
    Am J Kidney Dis; 1989 Jul; 14(1):76-7. PubMed ID: 2741938
    [No Abstract]   [Full Text] [Related]  

  • 45. Methotrexate therapy for juvenile rheumatoid arthritis.
    Feldman BM; Silverman ED
    J Pediatr; 1991 Jun; 118(6):992-3. PubMed ID: 2040940
    [No Abstract]   [Full Text] [Related]  

  • 46. Spotlight on etanercept in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR; Keating GM
    BioDrugs; 2003; 17(2):139-45. PubMed ID: 12641492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis.
    Ravelli A; Migliavacca D; Viola S; Ruperto N; Pistorio A; Martini A
    Clin Exp Rheumatol; 1999; 17(5):625-7. PubMed ID: 10544851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatic fibrosis with the use of methotrexate for juvenile rheumatoid arthritis.
    Keim D; Ragsdale C; Heidelberger K; Sullivan D
    J Rheumatol; 1990 Jun; 17(6):846-8. PubMed ID: 2388211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Abbott proposes in Europe and the U.S.A. the approval of Humira (adalimumab) for therapy of juvenile idiopathic arthritis. Pediatric clinical trial shows very promising results in juvenile rheumatoid arthritis].
    Shandwick W; Bude S
    Kinderkrankenschwester; 2007 Aug; 26(8):335-6. PubMed ID: 17844688
    [No Abstract]   [Full Text] [Related]  

  • 50. Strategies for the prevention and management of methotrexate-related nausea and vomiting in juvenile idiopathic arthritis: results of a UK Paediatric Rheumatology prescriber survey.
    Amin TS; Shenton S; Mulligan K; Wedderburn LR; Wood M; VanRooyen V; Leone V
    Rheumatology (Oxford); 2015 Nov; 54(11):2108-9. PubMed ID: 26209331
    [No Abstract]   [Full Text] [Related]  

  • 51. Etanercept: a review of its use in rheumatoid arthritis.
    Jarvis B; Faulds D
    Drugs; 1999 Jun; 57(6):945-66. PubMed ID: 10400407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
    Sante; 2001; 11(3):195-200. PubMed ID: 11641084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of methotrexate therapy for juvenile rheumatoid arthritis.
    Lin YT; Tsai MJ; Wang LH; Huang MT; Yang YH; Chiang BL
    J Formos Med Assoc; 2000 Aug; 99(8):623-9. PubMed ID: 10969505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methotrexate: long-term safety and efficacy in an Australian consultant rheumatology practice.
    Varatharajan N; Lim IG; Anandacoomarasamy A; Russo R; Byth K; Spencer DG; Manolios N; Howe GB
    Intern Med J; 2009 Apr; 39(4):228-36. PubMed ID: 19402861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of Serious Infection in Juvenile Idiopathic Arthritis Patients Associated With Tumor Necrosis Factor Inhibitors and Disease Activity in the German Biologics in Pediatric Rheumatology Registry.
    Becker I; Horneff G
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):552-560. PubMed ID: 27390133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methotrexate hepatotoxicity in children with leukemia.
    McIntosh S; Davidson DL; O'Brien RT; Pearson HA
    J Pediatr; 1977 Jun; 90(6):1019-21. PubMed ID: 870655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low-dose methotrexate in systemic onset juvenile chronic arthritis.
    Speckmaier M; Findeisen J; Woo P; Hall A; Sills JA; Price T; Hollingworth P; Craft A; Ansell BM
    Clin Exp Rheumatol; 1989; 7(6):647-50. PubMed ID: 2612084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine.
    Ravelli A; De Benedetti F; Viola S; Martini A
    J Pediatr; 1996 Feb; 128(2):275-8. PubMed ID: 8636829
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis.
    Weiss AH; Wallace CA; Sherry DD
    J Pediatr; 1998 Aug; 133(2):266-8. PubMed ID: 9709718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A patient with seropositive rheumatoid arthritis.
    Capell H
    Br J Rheumatol; 1989 Aug; 28(4):340. PubMed ID: 2743093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.